메뉴 건너뛰기




Volumn 27, Issue 2, 2016, Pages 123-135

Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification

Author keywords

Castration resistant prostate cancer (CRPC); Large cell neuroendocrine carcinoma; Molecular cytogenetics; Neuroendocrine differentiation; Prostate cancer; Small cell carcinoma

Indexed keywords

CELL TRANSDIFFERENTIATION; HISTOPATHOLOGY; HUMAN; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE NEUROENDOCRINE TUMOR; PROSTATE TUMOR; REVIEW; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; WORLD HEALTH ORGANIZATION; CARCINOMA; CLASSIFICATION; GENETICS; MALE; PATHOLOGY;

EID: 84958761514     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-016-9421-z     Document Type: Review
Times cited : (67)

References (98)
  • 3
    • 0035876175 scopus 로고    scopus 로고
    • Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin
    • Xing N, Qian J, Bostwick D, Bergstralh E and Young CY. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate. 2001; 48(1):7–15.
    • (2001) Prostate , vol.48 , Issue.1 , pp. 7-15
    • Xing, N.1    Qian, J.2    Bostwick, D.3    Bergstralh, E.4    Young, C.Y.5
  • 5
    • 84989220817 scopus 로고    scopus 로고
    • WHO Classification of Tumours of the Urinary System and Male Genital Organ: World Health Organization)
    • Moch H, Humphrey PA, Ulbright TM and Reuter VE. (2016). WHO Classification of Tumours of the Urinary System and Male Genital Organ: World Health Organization.
    • (2016) Ulbright TM and Reuter VE
    • Moch, H.1    Humphrey, P.A.2
  • 6
    • 0028354268 scopus 로고
    • Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases
    • Adlakha H and Bostwick DG. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol. 1994; 25(2):135–139.
    • (1994) Hum Pathol , vol.25 , Issue.2 , pp. 135-139
    • Adlakha, H.1    Bostwick, D.G.2
  • 7
    • 26844482718 scopus 로고    scopus 로고
    • Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
    • Abrahamsson PA, Cockett AT and di Sant’Agnese PA. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma. Prostate Suppl. 1998; 8:37–42.
    • (1998) Prostate Suppl , vol.8 , pp. 37-42
    • Abrahamsson, P.A.1    Cockett, A.T.2    di Sant’Agnese, P.A.3
  • 8
    • 0033962683 scopus 로고    scopus 로고
    • Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
    • Ahlgren G, Pedersen K, Lundberg S, Aus G, Hugosson J and Abrahamsson PA. Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate. 2000; 42(4):274–279.
    • (2000) Prostate , vol.42 , Issue.4 , pp. 274-279
    • Ahlgren, G.1    Pedersen, K.2    Lundberg, S.3    Aus, G.4    Hugosson, J.5    Abrahamsson, P.A.6
  • 9
    • 0029047613 scopus 로고
    • Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
    • Allen FJ, Van Velden DJ and Heyns CF. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer? Br J Urol. 1995; 75(6):751–754.
    • (1995) Br J Urol , vol.75 , Issue.6 , pp. 751-754
    • Allen, F.J.1    Van Velden, D.J.2    Heyns, C.F.3
  • 10
    • 0027319765 scopus 로고
    • Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
    • Aprikian AG, Cordon-Cardo C, Fair WR and Reuter VE. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer. 1993; 71(12):3952–3965.
    • (1993) Cancer , vol.71 , Issue.12 , pp. 3952-3965
    • Aprikian, A.G.1    Cordon-Cardo, C.2    Fair, W.R.3    Reuter, V.E.4
  • 12
    • 0029983124 scopus 로고    scopus 로고
    • Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy
    • Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P and Mihatsch MJ. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol. 1996; 178(4):437–441.
    • (1996) J Pathol , vol.178 , Issue.4 , pp. 437-441
    • Bubendorf, L.1    Sauter, G.2    Moch, H.3    Schmid, H.P.4    Gasser, T.C.5    Jordan, P.6    Mihatsch, M.J.7
  • 13
    • 0032322346 scopus 로고    scopus 로고
    • Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies
    • Casella R, Bubendorf L, Sauter G, Moch H, Mihatsch MJ and Gasser TC. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. J Urol. 1998; 160(2):406–410.
    • (1998) J Urol , vol.160 , Issue.2 , pp. 406-410
    • Casella, R.1    Bubendorf, L.2    Sauter, G.3    Moch, H.4    Mihatsch, M.J.5    Gasser, T.C.6
  • 14
    • 0028128330 scopus 로고
    • Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression
    • Cohen MK, Arber DA, Coffield KS, Keegan GT, McClintock J and Speights VO, Jr. Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer. 1994; 74(7):1899–1903.
    • (1994) Cancer , vol.74 , Issue.7 , pp. 1899-1903
    • Cohen, M.K.1    Arber, D.A.2    Coffield, K.S.3    Keegan, G.T.4    McClintock, J.5    Speights, V.O.6
  • 15
    • 59649093542 scopus 로고    scopus 로고
    • Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer
    • Ishida E, Nakamura M, Shimada K, Tasaki M and Konishi N. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer. Pathobiology. 2009; 76(1):30–38.
    • (2009) Pathobiology , vol.76 , Issue.1 , pp. 30-38
    • Ishida, E.1    Nakamura, M.2    Shimada, K.3    Tasaki, M.4    Konishi, N.5
  • 17
    • 0029113009 scopus 로고
    • The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy
    • Noordzij MA, van der Kwast TH, van Steenbrugge GJ, Hop WJ and Schroder FH. The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer. 1995; 62(3):252–258.
    • (1995) Int J Cancer , vol.62 , Issue.3 , pp. 252-258
    • Noordzij, M.A.1    van der Kwast, T.H.2    van Steenbrugge, G.J.3    Hop, W.J.4    Schroder, F.H.5
  • 18
    • 0034945566 scopus 로고    scopus 로고
    • Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer
    • Segawa N, Mori I, Utsunomiya H, Nakamura M, Nakamura Y, Shan L, Kakudo K and Katsuoka Y. Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. Pathol Int. 2001; 51(6):452–459.
    • (2001) Pathol Int , vol.51 , Issue.6 , pp. 452-459
    • Segawa, N.1    Mori, I.2    Utsunomiya, H.3    Nakamura, M.4    Nakamura, Y.5    Shan, L.6    Kakudo, K.7    Katsuoka, Y.8
  • 19
    • 33745822086 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer
    • Shariff AH and Ather MH. Neuroendocrine differentiation in prostate cancer. Urology. 2006; 68(1):2–8.
    • (2006) Urology , vol.68 , Issue.1 , pp. 2-8
    • Shariff, A.H.1    Ather, M.H.2
  • 20
    • 0031403615 scopus 로고    scopus 로고
    • Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples
    • Speights VO, Jr., Cohen MK, Riggs MW, Coffield KS, Keegan G and Arber DA. Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples. Br J Urol. 1997; 80(2):281–286.
    • (1997) Br J Urol , vol.80 , Issue.2 , pp. 281-286
    • Speights, V.O.1    Cohen, M.K.2    Riggs, M.W.3    Coffield, K.S.4    Keegan, G.5    Arber, D.A.6
  • 21
    • 33747591682 scopus 로고    scopus 로고
    • Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate
    • Tamas EF and Epstein JI. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. Am J Surg Pathol. 2006; 30(8):980–985.
    • (2006) Am J Surg Pathol , vol.30 , Issue.8 , pp. 980-985
    • Tamas, E.F.1    Epstein, J.I.2
  • 23
    • 0030015190 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy
    • Weinstein MH, Partin AW, Veltri RW and Epstein JI. Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum Pathol. 1996; 27(7):683–687.
    • (1996) Hum Pathol , vol.27 , Issue.7 , pp. 683-687
    • Weinstein, M.H.1    Partin, A.W.2    Veltri, R.W.3    Epstein, J.I.4
  • 25
    • 0031947318 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment
    • Jiborn T, Bjartell A and Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment. Urology. 1998; 51(4):585–589.
    • (1998) Urology , vol.51 , Issue.4 , pp. 585-589
    • Jiborn, T.1    Bjartell, A.2    Abrahamsson, P.A.3
  • 26
    • 0030947224 scopus 로고    scopus 로고
    • The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy
    • Krijnen JL, Bogdanowicz JF, Seldenrijk CA, Mulder PG and van der Kwast TH. The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy. J Urol. 1997; 158(1):171–174.
    • (1997) J Urol , vol.158 , Issue.1 , pp. 171-174
    • Krijnen, J.L.1    Bogdanowicz, J.F.2    Seldenrijk, C.A.3    Mulder, P.G.4    van der Kwast, T.H.5
  • 28
    • 79953701350 scopus 로고    scopus 로고
    • Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient’s tumor: morphological, immunohistochemical, and gene expression profiles
    • Aparicio A, Tzelepi V, Araujo JC, Guo CC, Liang S, Troncoso P, Logothetis CJ, Navone NM and Maity SN. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient’s tumor: morphological, immunohistochemical, and gene expression profiles. Prostate. 2011; 71(8):846–856.
    • (2011) Prostate , vol.71 , Issue.8 , pp. 846-856
    • Aparicio, A.1    Tzelepi, V.2    Araujo, J.C.3    Guo, C.C.4    Liang, S.5    Troncoso, P.6    Logothetis, C.J.7    Navone, N.M.8    Maity, S.N.9
  • 29
    • 84989215685 scopus 로고    scopus 로고
    • Kaur G, Singh B, Beltran H, Akhtar NH, Nanus DM and Tagawa ST. Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC). J Clin Oncol. 2014; (32):abstr 204
    • Kaur G, Singh B, Beltran H, Akhtar NH, Nanus DM and Tagawa ST. Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC). J Clin Oncol. 2014; (32):abstr 204.
  • 30
    • 84989238062 scopus 로고    scopus 로고
    • Marrinucci D: Dittamore R and Scher HI. The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer. Clin Cancer Res
    • Beltran H, Jendrisak A, Landers M, Mosquera JM, Kossai M, Louw J, Krupa R, Graf RP, Schreiber NA, Nanus DM, Tagawa ST, Marrinucci D, Dittamore R and Scher HI. The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer. Clin Cancer Res. 2015.
    • (2015) Tagawa ST
    • Beltran, H.1    Jendrisak, A.2    Landers, M.3    Mosquera, J.M.4    Kossai, M.5    Louw, J.6    Krupa, R.7    Graf, R.P.8    Schreiber, N.A.9    Nanus, D.M.10
  • 33
    • 35948929512 scopus 로고    scopus 로고
    • Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells
    • Yuan TC, Veeramani S and Lin MF. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer. 2007; 14(3):531–547.
    • (2007) Endocr Relat Cancer , vol.14 , Issue.3 , pp. 531-547
    • Yuan, T.C.1    Veeramani, S.2    Lin, M.F.3
  • 34
    • 0033370811 scopus 로고    scopus 로고
    • Neuroendocrine cells in tumour growth of the prostate
    • Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer. 1999; 6(4):503–519.
    • (1999) Endocr Relat Cancer , vol.6 , Issue.4 , pp. 503-519
    • Abrahamsson, P.A.1
  • 35
    • 0344457271 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostatic carcinoma
    • Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate. 1999; 39(2):135–148.
    • (1999) Prostate , vol.39 , Issue.2 , pp. 135-148
    • Abrahamsson, P.A.1
  • 37
    • 26844531799 scopus 로고    scopus 로고
    • Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status
    • Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate Suppl. 1998; 8:18–22.
    • (1998) Prostate Suppl , vol.8 , pp. 18-22
    • Bonkhoff, H.1
  • 38
    • 0025939537 scopus 로고
    • Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
    • Bonkhoff H, Wernert N, Dhom G and Remberger K. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate. 1991; 19(2):91–98.
    • (1991) Prostate , vol.19 , Issue.2 , pp. 91-98
    • Bonkhoff, H.1    Wernert, N.2    Dhom, G.3    Remberger, K.4
  • 39
    • 1842788109 scopus 로고    scopus 로고
    • Hirano D, Okada Y, Minei S, Takimoto Y and Nemoto N. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol. 2004; 45(5):586–592; discussion 592
    • Hirano D, Okada Y, Minei S, Takimoto Y and Nemoto N. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol. 2004; 45(5):586–592; discussion 592.
  • 40
    • 0034065893 scopus 로고    scopus 로고
    • Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
    • Mucci NR, Akdas G, Manely S and Rubin MA. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol. 2000; 31(4):406–414.
    • (2000) Hum Pathol , vol.31 , Issue.4 , pp. 406-414
    • Mucci, N.R.1    Akdas, G.2    Manely, S.3    Rubin, M.A.4
  • 42
    • 84942880558 scopus 로고    scopus 로고
    • Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment
    • Kadakia KC, Tomlins SA, Sanghvi SK, Cani AK, Omata K, Hovelson DH, Liu CJ and Cooney KA. Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. J Hematol Oncol. 2015; 8(1):109.
    • (2015) J Hematol Oncol , vol.8 , Issue.1 , pp. 109
    • Kadakia, K.C.1    Tomlins, S.A.2    Sanghvi, S.K.3    Cani, A.K.4    Omata, K.5    Hovelson, D.H.6    Liu, C.J.7    Cooney, K.A.8
  • 50
  • 54
    • 79961031503 scopus 로고    scopus 로고
    • ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
    • Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, Osunkoya AO, MacLennan GT, Montironi R and Cheng L. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol. 2011; 24(8):1120–1127.
    • (2011) Mod Pathol , vol.24 , Issue.8 , pp. 1120-1127
    • Williamson, S.R.1    Zhang, S.2    Yao, J.L.3    Huang, J.4    Lopez-Beltran, A.5    Shen, S.6    Osunkoya, A.O.7    MacLennan, G.T.8    Montironi, R.9    Cheng, L.10
  • 57
    • 0035328474 scopus 로고    scopus 로고
    • Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer
    • Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL and Visakorpi T. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res. 2001; 61(9):3550–3555.
    • (2001) Cancer Res , vol.61 , Issue.9 , pp. 3550-3555
    • Linja, M.J.1    Savinainen, K.J.2    Saramaki, O.R.3    Tammela, T.L.4    Vessella, R.L.5    Visakorpi, T.6
  • 59
    • 84923225609 scopus 로고    scopus 로고
    • Targeting neuroendocrine prostate cancer: molecular and clinical perspectives
    • Vlachostergios PJ and Papandreou CN. Targeting neuroendocrine prostate cancer: molecular and clinical perspectives. Front Oncol. 2015; 5:6.
    • (2015) Front Oncol , vol.5 , pp. 6
    • Vlachostergios, P.J.1    Papandreou, C.N.2
  • 61
    • 84877867710 scopus 로고    scopus 로고
    • p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia
    • Pignon JC, Grisanzio C, Geng Y, Song J, Shivdasani RA and Signoretti S. p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci U S A. 2013; 110(20):8105–8110.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.20 , pp. 8105-8110
    • Pignon, J.C.1    Grisanzio, C.2    Geng, Y.3    Song, J.4    Shivdasani, R.A.5    Signoretti, S.6
  • 63
    • 0037113943 scopus 로고    scopus 로고
    • Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice
    • Hu Y, Ippolito JE, Garabedian EM, Humphrey PA and Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem. 2002; 277(46):44462–44474.
    • (2002) J Biol Chem , vol.277 , Issue.46 , pp. 44462-44474
    • Hu, Y.1    Ippolito, J.E.2    Garabedian, E.M.3    Humphrey, P.A.4    Gordon, J.I.5
  • 64
    • 0032446247 scopus 로고    scopus 로고
    • A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
    • Garabedian EM, Humphrey PA and Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci U S A. 1998; 95(26):15382–15387.
    • (1998) Proc Natl Acad Sci U S A , vol.95 , Issue.26 , pp. 15382-15387
    • Garabedian, E.M.1    Humphrey, P.A.2    Gordon, J.I.3
  • 67
    • 84947441165 scopus 로고    scopus 로고
    • Neuroendocrine differentiation of prostate cancer: a review
    • Parimi V, Goyal R, Poropatich K and Yang XJ. Neuroendocrine differentiation of prostate cancer: a review. Am J Clin Exp Urol. 2014; 2(4):273–285.
    • (2014) Am J Clin Exp Urol , vol.2 , Issue.4 , pp. 273-285
    • Parimi, V.1    Goyal, R.2    Poropatich, K.3    Yang, X.J.4
  • 68
    • 77953404414 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer
    • Sun Y, Niu J and Huang J. Neuroendocrine differentiation in prostate cancer. Am J Transl Res. 2009; 1(2):148–162.
    • (2009) Am J Transl Res , vol.1 , Issue.2 , pp. 148-162
    • Sun, Y.1    Niu, J.2    Huang, J.3
  • 69
    • 21844454221 scopus 로고    scopus 로고
    • Puccetti L, Supuran CT, Fasolo PP, Conti E, Sebastiani G, Lacquaniti S, Mandras R, Milazzo MG, Dogliani N, De Giuli P and Fasolis G. Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer. Eur Urol. 2005; 48(2):215–221; Discussion 221–213
    • Puccetti L, Supuran CT, Fasolo PP, Conti E, Sebastiani G, Lacquaniti S, Mandras R, Milazzo MG, Dogliani N, De Giuli P and Fasolis G. Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer. Eur Urol. 2005; 48(2):215–221; Discussion 221–213.
  • 70
    • 0036332341 scopus 로고    scopus 로고
    • Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients
    • Tarle M, Ahel MZ and Kovacic K. Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients. Anticancer Res. 2002; 22(4):2525–2529.
    • (2002) Anticancer Res , vol.22 , Issue.4 , pp. 2525-2529
    • Tarle, M.1    Ahel, M.Z.2    Kovacic, K.3
  • 72
    • 0025901008 scopus 로고
    • Neuro-endocrine cells--a new prognostic parameter in prostate cancer
    • Cohen RJ, Glezerson G and Haffejee Z. Neuro-endocrine cells--a new prognostic parameter in prostate cancer. Br J Urol. 1991; 68(3):258–262.
    • (1991) Br J Urol , vol.68 , Issue.3 , pp. 258-262
    • Cohen, R.J.1    Glezerson, G.2    Haffejee, Z.3
  • 73
    • 84912572534 scopus 로고    scopus 로고
    • Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5
    • So JS, Gordetsky J and Epstein JI. Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5. Hum Pathol. 2014; 45(12):2388–2393.
    • (2014) Hum Pathol , vol.45 , Issue.12 , pp. 2388-2393
    • So, J.S.1    Gordetsky, J.2    Epstein, J.I.3
  • 74
    • 78549264795 scopus 로고    scopus 로고
    • A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
    • Giordano S, Tolonen T, Tolonen T, Hirsimaki S and Kataja V. A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Int Urol Nephrol. 2010; 42(3):683–687.
    • (2010) Int Urol Nephrol , vol.42 , Issue.3 , pp. 683-687
    • Giordano, S.1    Tolonen, T.2    Tolonen, T.3    Hirsimaki, S.4    Kataja, V.5
  • 76
    • 0028952423 scopus 로고
    • Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child
    • Whelan T, Gatfield CT, Robertson S, Carpenter B and Schillinger JF. Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child. J Urol. 1995; 153(3 Pt 2):1080–1082.
    • (1995) J Urol , vol.153 , Issue.3 , pp. 1080-1082
    • Whelan, T.1    Gatfield, C.T.2    Robertson, S.3    Carpenter, B.4    Schillinger, J.F.5
  • 77
    • 37549037864 scopus 로고    scopus 로고
    • Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases
    • Wang W and Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008; 32(1):65–71.
    • (2008) Am J Surg Pathol , vol.32 , Issue.1 , pp. 65-71
    • Wang, W.1    Epstein, J.I.2
  • 78
    • 84857657168 scopus 로고    scopus 로고
    • Survival of patients with small cell carcinoma of the prostate during 1973–2003: a population-based study
    • Deorah S, Rao MB, Raman R, Gaitonde K and Donovan JF. Survival of patients with small cell carcinoma of the prostate during 1973–2003: a population-based study. BJU Int. 2012; 109(6):824–830.
    • (2012) BJU Int , vol.109 , Issue.6 , pp. 824-830
    • Deorah, S.1    Rao, M.B.2    Raman, R.3    Gaitonde, K.4    Donovan, J.F.5
  • 79
    • 0034075111 scopus 로고    scopus 로고
    • Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors
    • Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD and Folpe AL. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000; 13(3):238–242.
    • (2000) Mod Pathol , vol.13 , Issue.3 , pp. 238-242
    • Agoff, S.N.1    Lamps, L.W.2    Philip, A.T.3    Amin, M.B.4    Schmidt, R.A.5    True, L.D.6    Folpe, A.L.7
  • 80
    • 0035110093 scopus 로고    scopus 로고
    • Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas
    • Cheuk W, Kwan MY, Suster S and Chan JK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med. 2001; 125(2):228–231.
    • (2001) Arch Pathol Lab Med , vol.125 , Issue.2 , pp. 228-231
    • Cheuk, W.1    Kwan, M.Y.2    Suster, S.3    Chan, J.K.4
  • 82
    • 0034105401 scopus 로고    scopus 로고
    • Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites
    • Kaufmann O and Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology. 2000; 36(5):415–420.
    • (2000) Histopathology , vol.36 , Issue.5 , pp. 415-420
    • Kaufmann, O.1    Dietel, M.2
  • 83
    • 77955749693 scopus 로고    scopus 로고
    • Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features
    • Li AF, Li AC, Hsu CY, Li WY, Hsu HS and Chen JY. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features. J Clin Pathol. 2010; 63(7):620–625.
    • (2010) J Clin Pathol , vol.63 , Issue.7 , pp. 620-625
    • Li, A.F.1    Li, A.C.2    Hsu, C.Y.3    Li, W.Y.4    Hsu, H.S.5    Chen, J.Y.6
  • 84
    • 77953158473 scopus 로고    scopus 로고
    • Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases
    • Lu J, Xue LY, Lu N, Zou SM, Liu XY and Wen P. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases. Dis Esophagus. 2010; 23(2):153–159.
    • (2010) Dis Esophagus , vol.23 , Issue.2 , pp. 153-159
    • Lu, J.1    Xue, L.Y.2    Lu, N.3    Zou, S.M.4    Liu, X.Y.5    Wen, P.6
  • 85
    • 77950241708 scopus 로고    scopus 로고
    • Neoplasms that are commonly TTF1 positive and which may express CK20 and P63
    • McCluggage WG, Kennedy K and Busam KJ. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol. 2010; 34(4):525–532.
    • (2010) Am J Surg Pathol , vol.34 , Issue.4 , pp. 525-532
    • McCluggage, W.G.1    Kennedy, K.2
  • 86
    • 66149120348 scopus 로고    scopus 로고
    • Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
    • Yun JP, Zhang MF, Hou JH, Tian QH, Fu J, Liang XM, Wu QL and Rong TH. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer. 2007; 7:38.
    • (2007) BMC Cancer , vol.7 , pp. 38
    • Yun, J.P.1    Zhang, M.F.2    Hou, J.H.3    Tian, Q.H.4    Fu, J.5    Liang, X.M.6    Wu, Q.L.7    Rong, T.H.8
  • 88
    • 84925588586 scopus 로고    scopus 로고
    • Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma
    • Wang CC, De Marzo AM, Lotan TL and Epstein JI. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma. Hum Pathol. 2015; 46(4):554–557.
    • (2015) Hum Pathol , vol.46 , Issue.4 , pp. 554-557
    • Wang, C.C.1    De Marzo, A.M.2    Lotan, T.L.3    Epstein, J.I.4
  • 90
    • 0015252266 scopus 로고
    • Occurrence and prognosis of extranodal lymphomas
    • Freeman C, Berg JW and Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972; 29(1):252–260.
    • (1972) Cancer , vol.29 , Issue.1 , pp. 252-260
    • Freeman, C.1    Berg, J.W.2    Cutler, S.J.3
  • 91
    • 0023679776 scopus 로고
    • Primary prostatic involvement in non-Hodgkin lymphoma
    • Patel DR, Gomez GA, Henderson ES and Gamarra M. Primary prostatic involvement in non-Hodgkin lymphoma. Urology. 1988; 32(2):96–98.
    • (1988) Urology , vol.32 , Issue.2 , pp. 96-98
    • Patel, D.R.1    Gomez, G.A.2    Henderson, E.S.3    Gamarra, M.4
  • 92
    • 0029006130 scopus 로고
    • Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy
    • Sarris A, Dimopoulos M, Pugh W and Cabanillas F. Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy. J Urol. 1995; 153(6):1852–1854.
    • (1995) J Urol , vol.153 , Issue.6 , pp. 1852-1854
    • Sarris, A.1    Dimopoulos, M.2    Pugh, W.3    Cabanillas, F.4
  • 93
    • 0032446748 scopus 로고    scopus 로고
    • CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall
    • Nandedkar MA, Palazzo J, Abbondanzo SL, Lasota J and Miettinen M. CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall. Mod Pathol. 1998; 11(12):1204–1210.
    • (1998) Mod Pathol , vol.11 , Issue.12 , pp. 1204-1210
    • Nandedkar, M.A.1    Palazzo, J.2    Abbondanzo, S.L.3    Lasota, J.4    Miettinen, M.5
  • 94
    • 0032460558 scopus 로고    scopus 로고
    • Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival
    • Mackey JR, Au HJ, Hugh J and Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol. 1998; 159(5):1624–1629.
    • (1998) J Urol , vol.159 , Issue.5 , pp. 1624-1629
    • Mackey, J.R.1    Au, H.J.2    Hugh, J.3    Venner, P.4
  • 95
    • 33745895892 scopus 로고    scopus 로고
    • Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer
    • Evans AJ, Humphrey PA, Belani J, van der Kwast TH and Srigley JR. Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol. 2006; 30(6):684–693.
    • (2006) Am J Surg Pathol , vol.30 , Issue.6 , pp. 684-693
    • Evans, A.J.1    Humphrey, P.A.2    Belani, J.3    van der Kwast, T.H.4    Srigley, J.R.5
  • 96
    • 84255199223 scopus 로고    scopus 로고
    • Histological variants of prostatic carcinoma and their significance
    • Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology. 2012; 60(1):59–74.
    • (2012) Histopathology , vol.60 , Issue.1 , pp. 59-74
    • Humphrey, P.A.1
  • 97
    • 84921459341 scopus 로고    scopus 로고
    • De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature
    • Okoye E, Choi EK, Divatia M, Miles BJ, Ayala AG and Ro JY. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. Int J Clin Exp Pathol. 2014; 7(12):9061–9066.
    • (2014) Int J Clin Exp Pathol , vol.7 , Issue.12 , pp. 9061-9066
    • Okoye, E.1    Choi, E.K.2    Divatia, M.3    Miles, B.J.4    Ayala, A.G.5    Ro, J.Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.